Heads of International Research Organizations

Rhythm Pharmaceuticals and Genpharm Announce Collaboration to Provide IMCIVREE® (setmelanotide) to Patients in Gulf Cooperation Council Countries

Retrieved on: 
Monday, May 22, 2023
Polyphagia, LEPR, Obesity, International, Prevalence, GCC, Bardet–Biedl syndrome, POMC, BBS, Patient, PCSK1, European, United Kingdom, MC4R, Gulf Cooperation Council, Rare, Heads of International Research Organizations, Pharmaceutical industry

Under the terms of this exclusive agreement, Genpharm will distribute IMCIVREE to patients in GCC countries for the treatment of hyperphagia and obesity due to Bardet-Biedl syndrome (BBS) or genetically-confirmed biallelic pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency.

Key Points: 
  • Under the terms of this exclusive agreement, Genpharm will distribute IMCIVREE to patients in GCC countries for the treatment of hyperphagia and obesity due to Bardet-Biedl syndrome (BBS) or genetically-confirmed biallelic pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency.
  • IMCIVREE is approved for these indications in the United States, Canada, the United Kingdom and the European Union.
  • Providers in the region now have the ability to prescribe IMCIVREE to qualifying patients who they believe will benefit from the therapy.
  • “Due to many factors, GCC countries have an increased prevalence of certain genetic diseases, creating a significant demand for precision therapies, like IMCIVREE, that address illnesses at their root cause,” said Kamel Ghammachi, Genpharm Chairman.

Experian Named Global Fintech Leader in Center for Financial Professionals 2022 Report

Retrieved on: 
Thursday, December 9, 2021
Technology, Finance, Consulting, Security, Other Technology, Professional Services, Software, Internet, Data Management, Credit risk, Research, London, Group, Financial technology, Blog, EXPN, Science and technology in Asia, News, Industry, Heads of International Research Organizations, Center, FTSE, Fraud, Finance, Child, Crime, Center for Financial Studies, London Stock Exchange, Online shopping, Experian, Center for Financial Professionals CeFPro®, EXPERIAN, CENTER FOR FINANCIAL PROFESSIONALS CEFPRO®

Experian, the worlds leading global information services company, has been named a global fintech leader in the Center for Financial Professionals (CeFPro) Fintech Leaders 2022 report.

Key Points: 
  • Experian, the worlds leading global information services company, has been named a global fintech leader in the Center for Financial Professionals (CeFPro) Fintech Leaders 2022 report.
  • The list and adjoining report are released annually by the international research organization, which recognizes exceptional performance among key players in the financial services and fintech spaces.
  • The Center for Financial Professionals Fintech Leaders 2022 Report evaluates the status of top fintech companies, solution providers, and vendors.
  • The Center for Financial Professionals (CeFPro) is an international research organization and the focal point for financial risk professionals to advance through renowned thought-leadership, knowledge sharing, unparalleled networking, industry solutions and lead generation.

KHIDI Korean Pavilion for 'HIMSS Europe Digital Event'

Retrieved on: 
Thursday, September 3, 2020
Health informatics, Articles, Telehealth, Health, Healthcare Information and Management Systems Society, Healthcare industry, Health 2.0, Digital health, Heads of International Research Organizations

HELSINKI, Sept. 3, 2020 /PRNewswire/ --Korea Health Industry Development Institute (KHIDI) is planning to participate in 'HIMSS & Health 2.0 European Digital Event' held for 5 days from September 7th to 11th, 2020 with competitive digital healthcare companies in Korea.

Key Points: 
  • HELSINKI, Sept. 3, 2020 /PRNewswire/ --Korea Health Industry Development Institute (KHIDI) is planning to participate in 'HIMSS & Health 2.0 European Digital Event' held for 5 days from September 7th to 11th, 2020 with competitive digital healthcare companies in Korea.
  • KHIDI is the government-affiliated institution which carries out the systematic and professional support for the improvement of public health and enhancement of the international competitiveness in the health industry.
  • KHIDI has been specifically leading the development of the health industry such as medical services, pharmaceuticals, medical devices, foreign patient attraction, and digital healthcare industry.
  • In particular, in the HIMSS European event, the Korea Pavilion was operated by recruiting companies for three consecutive years following 2018 and 2019.